Evidence map›Paper›PMID 17961256›Full record

ArticleBMC health services research2007

Impact of prescription size on statin adherence and cholesterol levels.

Holly A Batal, Mori J Krantz, Rita A Dale, Phillip S Mehler, John F Steiner

Full text read
In one paragraph

Article in BMC health services research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Impact of issuing longer- versus shorter-duration prescriptions: a systematic review.The British journal of general practice : the journal of the Royal College of General Practitioners · 2018
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Adherence to chronic disease medications among New York City Medicaid participants.Journal of urban health : bulletin of the New York Academy of Medicine · 2013
    Article
  20. How patient cost-sharing trends affect adherence and outcomes: a literature review.P & T : a peer-reviewed journal for formulary management · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Holly A BatalGeneral Internal Medicine, Denver Health and Hospital Authority, 777 Bannock St,, Box 0148, Denver, CO 80204, USA. Holly.Batal@dhha.org
Mori J Krantz
Rita A Dale
Phillip S Mehler
John F Steiner

Funding

Latinos Using Cardio Health Actions to Reduce RiskU01HL079208 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BULL, SHEANA S · 2004 to 2008
$2.9M
NHLBI NIH HHS 1 U01 HL079208NHLBI NIH HHS U01 HL079208PHS HHS 1 D14 HP 00153
6 · The paper itself

Abstract

backgroundTherapy with 3-Hydroxy-3-methylglutaryl Co-enzyme A reductase inhibitors (statins) improve outcomes in a broad spectrum of patients with hyperlipidemia. However, effective therapy requires ongoing medication adherence; restrictive pharmacy policies may represent a barrier to successful adherence, particularly among vulnerable patients. In this study we sought to assess the relationship between the quantity of statin dispensed by the pharmacy with patient adherence and total cholesterol.

methodsWe analyzed a cohort of 3,386 patients receiving more than one fill of statin medications through an integrated, inner-city health care system between January 1, 2000 and December 31, 2002. Our measure of adherence was days of drug acquisition divided by days in the study for each patient, with adequate adherence defined as > or = 80%. Log-binomial regression was used to determine the relative risk of various factors, including prescription size, on adherence. We also assessed the relationship between adherence and total cholesterol using multiple linear regression.

resultsAfter controlling for age, gender, race, co-payment, comorbidities, and insurance status, patients who obtained a majority of fills as 60-day supply compared with 30-day supply were more likely to be adherent to their statin medications (RR 1.41, 95% CI 1.28-1.55, P < 0.01). We found that statin non-adherence less than 80% was predictive of higher total serum cholesterol by 17.23 +/- 1.64 mg/dL (0.45 +/- 0.04 mmol/L).

conclusionIn a healthcare system serving predominantly indigent patients, the provision of a greater quantity of statin medication at each prescription fill contributes to improved adherence and greater drug effectiveness.

Indexed as

AgedAge FactorsCholesterolCohort StudiesColoradoDelivery of Health Care, IntegratedDrug PrescriptionsFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHyperlipidemiasLinear ModelsMaleMiddle AgedPatient CompliancePharmaceutical ServicesCholesterolHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID17961256
PMCPMC2174936

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.